ERBB2 and breast carcinoma: There is a general concern that erbB2+ breast cancer cell lines are difficult to form spontaneous xenografts in athymic nu/nu mice [33], and it is not known whether the BT474-HR20 cells would maintain their trastuzumab-resistant phenotype in vivo.